Literature DB >> 17345790

Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome.

Hisashi Masugata1, Shoichi Senda, Fuminori Goda, Yumiko Yoshihara, Kay Yoshikawa, Norihiro Fujita, Hiroyuki Daikuhara, Hiroyuki Nakamura, Teruhisa Taoka, Masakazu Kohno.   

Abstract

The purpose of the present study was to elucidate the cardiac structure and function in patients who have metabolic syndrome but no history of cardiovascular disease by analyzing echocardiographic findings. Echocardiographic examination was performed to screen for cardiovascular disease in 135 patients who were in their sixties. Patients were divided into metabolic syndrome (n=65, age: 65+/-2.7 years) and non-metabolic syndrome (n=70, age: 66+/-2.5 years) groups based on the criteria for metabolic syndrome proposed by the Japanese Society of Hypertension and seven other societies in 2005. The left ventricular (LV) wall thickness and dimension were measured by M-mode echocardiography. The relative wall thickness, LV mass index, and LV ejection fraction (LVEF) were calculated. LV diastolic function was assessed by the peak velocity of early rapid filling (E velocity) and the peak velocity of atrial filling (A velocity), and the ratio of E to A (E/A) was assessed by the transmitral flow. The Tei index, which reflects both LV diastolic and systolic function, was also calculated. There were no differences in relative wall thickness, LV mass index, or LVEF between the two groups. However, both the EIA and Tei index were significantly different between the metabolic syndrome (0.66+/-0.14 and 0.36+/-0.07, respectively) and non-metabolic syndrome (0.88+/-0.25 and 0.29+/-0.09) groups (p<0.001). These results indicate that patients with metabolic syndrome can have cardiac diastolic dysfunction even if they have neither LV hypertrophy nor systolic dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 17345790     DOI: 10.1291/hypres.29.897

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  22 in total

1.  Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats.

Authors:  Shan-Shan Xing; Xiu-Ping Bi; Hong-Wei Tan; Yun Zhang; Qi-Chong Xing; Wei Zhang
Journal:  Mol Med       Date:  2010-07-12       Impact factor: 6.354

2.  Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals.

Authors:  Yi-Chih Wang; Chang-Seng Liang; Deepa M Gopal; Nir Ayalon; Courtney Donohue; Rajalakshmi Santhanakrishnan; Harpaul Sandhu; Alejandro J Perez; Jill Downing; Noyan Gokce; Wilson S Colucci; Jennifer E Ho
Journal:  Circ Heart Fail       Date:  2015-07-14       Impact factor: 8.790

3.  Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN study.

Authors:  G de Simone; D K Arnett; M Chinali; M De Marco; D C Rao; A T Kraja; S C Hunt; R B Devereux
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-05-12       Impact factor: 4.222

4.  Regional myocardial function abnormalities are associated with macro- and microcirculation dysfunction in the metabolic syndrome: the RESOLVE study.

Authors:  Philippe Obert; Guillaume Walther; Frédéric Dutheil; Bruno Lesourd; Robert Chapier; Daniel Courteix; Agnes Vinet
Journal:  Heart Vessels       Date:  2018-01-19       Impact factor: 2.037

Review 5.  Role of autophagy in metabolic syndrome-associated heart disease.

Authors:  Sidney Y Ren; Xihui Xu
Journal:  Biochim Biophys Acta       Date:  2014-05-05

6.  Association of the metabolic syndrome with pulmonary venous hypertension.

Authors:  Ivan M Robbins; John H Newman; Roger F Johnson; Anna R Hemnes; Richard D Fremont; Robert N Piana; David X Zhao; Daniel W Byrne
Journal:  Chest       Date:  2009-02-02       Impact factor: 9.410

7.  Preclinical left ventricular diastolic dysfunction in metabolic syndrome.

Authors:  Nir Ayalon; Deepa M Gopal; Deirdre M Mooney; Juliana S Simonetti; Jason R Grossman; Aeshita Dwivedi; Courtney Donohue; Alejandro J Perez; Jill Downing; Noyan Gokce; Edward J Miller; Chang-Seng Liang; Caroline M Apovian; Wilson S Colucci; Jennifer E Ho
Journal:  Am J Cardiol       Date:  2014-07-01       Impact factor: 2.778

8.  Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study.

Authors:  Pinchia Huang; Aldi T Kraja; Weihong Tang; Steven C Hunt; Kari E North; Cora E Lewis; Richard B Devereux; Giovanni de Simone; Donna K Arnett; Treva Rice; Dabeeru C Rao
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

9.  Metabolic syndrome and left ventricular function: is the number of criteria actually important?

Authors:  Marijana Tadic; Branislava Ivanovic; Nada Kostic; Dragan Simic; Danica Matic; Vera Celic
Journal:  Med Sci Monit       Date:  2012-05

10.  Subclinical Myocardial Dysfunction in Metabolic Syndrome Patients without Hypertension.

Authors:  Jeong-Min Seo; Tae-Ho Park; Dong-Yeol Lee; Young-Rak Cho; Hee-Kyung Baek; Jong-Seong Park; Moo-Hyun Kim; Young-Dae Kim; Sun-Young Choi; Sun-Mi Lee; Young-Seoub Hong
Journal:  J Cardiovasc Ultrasound       Date:  2011-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.